HGH (Somatropin)

Overview

Recombinant human growth hormone is chemically identical to what the pituitary produces. Medically it treats growth hormone deficiency; everything described here is off-label.

What distinguishes it from almost every other substance in this field is the time scale. HGH does not work in weeks but in months — effects on connective tissue, skin and body composition build gradually. Anyone assessing after four weeks is assessing too early, and the frequent disappointment with short courses stems from that mismatch rather than from the substance.

Mechanism of Action

Growth hormone acts partly directly and partly through IGF-1, which the liver produces in response. IGF-1 mediates most of the anabolic effects, which is why it is the marker measured in practice — GH itself is released in pulses and fluctuates too much to be meaningful in a single blood draw.

The metabolic effect runs in two directions. GH promotes lipolysis, the breakdown of fat, and simultaneously reduces the effect of insulin on cells. That second part is not a side effect at the margin — it is the central problem of prolonged use.

Insulin and growth hormone are functional opposites. Sustained elevated GH means the body needs more insulin for the same effect on blood glucose. Over months this can progress from reduced sensitivity to manifest insulin resistance, and this is what limits duration and dose far more than any acute side effect.

The effects on connective tissue, tendons and skin are real and are the reason lower doses over longer periods are often the more sensible use than high doses over a short one.

Typical Context

Two approaches exist, and they differ more than the dose suggests.

Low doses of two to three IU daily over several months target recovery, connective tissue and skin. Side effects stay largely manageable at this level, and insulin sensitivity is affected but not usually driven into the problematic range.

Higher doses of four to six IU and above target body composition. Here water retention, carpal tunnel symptoms and rising blood glucose become noticeable. Above that range, the effects that are visible in some competitive physiques appear — organ growth, including of the intestines. Those changes are not reversible in the way water retention is.

The frequently debated question of injection timing matters less than either the dose or the duration. What matters far more is running it long enough to see anything at all, and checking glucose values while doing so.

Side Effects & Risks

• Rising blood glucose, reduced insulin sensitivity, potentially manifest insulin resistance
• Water retention, carpal tunnel symptoms, joint pain
• Organ and tissue growth with high doses over long periods
• Suppression of the body's own GH production
• Accelerated growth of existing tumours
• Elevated blood pressure
• Fatigue after administration
• High counterfeit rate and sensitivity to broken cold chains

Blood Work & Monitoring

• IGF-1 — the practical measure of effect; GH itself fluctuates too much to measure usefully
• Fasting glucose, HbA1c and fasting insulin — the limiting factor; check regularly, not once
• Thyroid values (TSH, fT3, fT4) — GH influences thyroid conversion
• Blood pressure — measured at home
• Lipid profile (LDL, HDL, triglycerides)

Harm-Reduction Notes

• Insulin sensitivity is the deciding limit — measure glucose and HbA1c regularly, not just at the start
• Carpal tunnel symptoms and water retention mean the dose is too high; reduce rather than push through
• Plan for months, not weeks; short courses show little and waste money
• Lower doses over longer periods are usually the more sensible trade-off
• Existing or suspected malignancy is an absolute contraindication
• Only pharmaceutical product; the counterfeit rate is high and the cold chain matters
• Reconstituted product must stay refrigerated and has a limited shelf life